376 related articles for article (PubMed ID: 29529421)
1. Clozapine use in geriatric patients- Challenges.
Mukku SSR; Sivakumar PT; Varghese M
Asian J Psychiatr; 2018 Mar; 33():63-67. PubMed ID: 29529421
[TBL] [Abstract][Full Text] [Related]
2. Clozapine: balancing safety with superior antipsychotic efficacy.
Meltzer HY
Clin Schizophr Relat Psychoses; 2012 Oct; 6(3):134-44. PubMed ID: 23006238
[TBL] [Abstract][Full Text] [Related]
3. Management of the adverse effects of clozapine.
Young CR; Bowers MB; Mazure CM
Schizophr Bull; 1998; 24(3):381-90. PubMed ID: 9718630
[TBL] [Abstract][Full Text] [Related]
4. Failure of rechallenge clozapine after agranulocytosis: A case report.
Roméo B; Petillion A; Martelli C; Benyamina A
Encephale; 2019 Nov; 45(5):449-450. PubMed ID: 30878138
[No Abstract] [Full Text] [Related]
5. Agranulocytosis in a second clozapine trial.
Gupta S; Noor-Khan N; Frank B
Psychiatr Serv; 1998 Aug; 49(8):1094. PubMed ID: 9712222
[No Abstract] [Full Text] [Related]
6. Clozapine alone versus clozapine and risperidone for refractory schizophrenia.
Gerson SL
N Engl J Med; 2006 Apr; 354(17):1846-8; author reply 1846-8. PubMed ID: 16642587
[No Abstract] [Full Text] [Related]
7. Psychopharmacology. Clozapine and agranulocytosis.
Feldman J
Psychiatr Serv; 1996 Nov; 47(11):1177-8. PubMed ID: 8916231
[No Abstract] [Full Text] [Related]
8. Late-onset agranulocytosis in a patient treated with clozapine and lamotrigine.
Tourian L; Margolese HC
J Clin Psychopharmacol; 2011 Oct; 31(5):665-7. PubMed ID: 21881454
[No Abstract] [Full Text] [Related]
9. Clozapine-induced agranulocytosis after 11 years of treatment.
Sedky K; Shaughnessy R; Hughes T; Lippmann S
Am J Psychiatry; 2005 Apr; 162(4):814. PubMed ID: 15800170
[No Abstract] [Full Text] [Related]
10. Review and management of clozapine side effects.
Miller DD
J Clin Psychiatry; 2000; 61 Suppl 8():14-7; discussion 18-9. PubMed ID: 10811238
[TBL] [Abstract][Full Text] [Related]
11. [Clozapine in treatment of neuropsychiatric diseases in the elderly].
Retz W; Rösler M; Sitzmann L; Becker T
Fortschr Neurol Psychiatr; 1997 Aug; 65(8):347-53. PubMed ID: 9378447
[TBL] [Abstract][Full Text] [Related]
12. Add-on filgrastim during clozapine rechallenge in patients with a history of clozapine-related granulocytopenia/agranulocytosis.
Joffe G; Eskelinen S; Sailas E
Am J Psychiatry; 2009 Feb; 166(2):236. PubMed ID: 19188296
[No Abstract] [Full Text] [Related]
13. Clozapine use in children and adolescents.
Gogtay N; Rapoport J
Expert Opin Pharmacother; 2008 Feb; 9(3):459-65. PubMed ID: 18220495
[TBL] [Abstract][Full Text] [Related]
14. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
Hägg S; Rosenius S; Spigset O
Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
[TBL] [Abstract][Full Text] [Related]
15. Controls on clozapine must be reviewed.
Drew LR
Aust N Z J Psychiatry; 2010 May; 44(5):490. PubMed ID: 20397797
[No Abstract] [Full Text] [Related]
16. Should the clozapine protocol be obeyed?
Drew L
Aust N Z J Psychiatry; 2011 Sep; 45(9):790. PubMed ID: 21668297
[No Abstract] [Full Text] [Related]
17. [Patient knowledge regarding Clozapine-induced agranulocytosis].
Haberfellner EM; Rittmannsberger H
Psychiatr Prax; 2006 May; 33(4):194-6. PubMed ID: 16680627
[No Abstract] [Full Text] [Related]
18. [Reversible clozapine-induced agranulocytosis].
Nery-Fernandes F; Silveira VP; Quarantini LC; Coutinho DM; Scippa AM
Braz J Psychiatry; 2006 Jun; 28(2):162. PubMed ID: 16810407
[No Abstract] [Full Text] [Related]
19. Optimizing clozapine treatment.
Naber D
J Clin Psychiatry; 1999; 60 Suppl 12():35-8. PubMed ID: 10372609
[TBL] [Abstract][Full Text] [Related]
20. Granulocytopenia with clozapine and quetiapine.
Diaz P; Hogan TP
Am J Psychiatry; 2001 Apr; 158(4):651. PubMed ID: 11282709
[No Abstract] [Full Text] [Related]
[Next] [New Search]
